Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren in HFNEF
NCT00982033Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jul 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aliskiren in heart failure with preserved ejection fraction (HFpEF), sponsored by Wake Forest University Health Sciences. Started Jul 2009; status: completed.
02
Drugs
aliskiren
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT00982033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00982033.